Distant organ metastases are still the leading cause of cancer-related deaths (104), and the KMT2C gene, a high-frequency mutated gene common to both primary and metastatic foci of lung cancer, may provide a potential biomarker for immune checkpoint blockade in LUAD with metastases to different organs (105). This evidence concerns the gene KMT2C and cancer.